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Background: Matrix metalloproteinases (MMPs) degrade the extracellular matrix (ECM) and regulate remodeling and
regeneration of bone. Enamel matrix derivative (EMD) protein has been used clinically for periodontal regeneration,
although its molecular mechanisms are not clear. We evaluated the role of matrix metalloproteinases (MMPs) in
regulating EMD-dependent degradation of gelatin on oeoblast-like cell line MG63.
Methods: MG-63 cells (osteoblast cell line) were incubated with 100 μg/ml EMD protein in the presence or absence of
MMP-2 tissue inhibitor for 20 h followed by incubation on DQ-gelatin-coated plates for 4 h. MG-63 cells (1 × 106) were
preincubated with SB203580 for 30 min at 37°C and were then placed in 100 μg/ml EMD protein for 24 h. Conditioned
media were collected and detected by Western blot analysis.
Results: EMD protein enhanced cell-mediated degradation of gelatin, which was inhibited by the MMP inhibitor TIMP-2.
Furthermore, MMP-2 was produced by MG63 cells in response to EMD protein in a P38 MAPK-dependent manner. In
addition, blocking of p38 MAPK activation by SB203580 significantly inhibited generation of the active form of MMP-2.
Conclusion: P38 MAPK pathway promotes expression MMP-2 in EMD activated osteoblasts, which in turn stimulates
periodontal regeneration by degrading matrix proteins in periodontal connective tissue.Background
Two major objectives of periodontal therapy are regen-
erating the periodontal ligament (PDL) and rebuilding
alveolar bone lost as a result of periodontal disease. Pre-
vious experimental models and clinical studies have shown
that enamel matrix-derived (EMD) protein promotes
generation of PDL, root cementum and alveolar bone
[1-3]. EMD protein also activates osteoblasts cells in vitro,
leading to a wound-healing response [4] and generation
of alkaline phosphatase [5]. In addition, EMD protein
regulates the production of matrix metalloproteinases
(MMPs) and tissue inhibitors of MMPs (TIMPs) in gingival
crevicular fluid [6,7].
Bone is continuously remodeled, and the amount of new
bone depends on the balance between bone formation and
resorption, which are mediated by osteoblasts, osteoclasts
and osteocytes. Disturbed extracellular matrix (ECM)
turnover leads to bone loss and its associated diseases,* Correspondence: goda@cc.osaka-dent.ac.jp
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unless otherwise stated.such as periodontitis. Osteoblasts are bone-remodeling
cells that differentiate from mesenchymal stem cells and
secrete ECM protein, which is subsequently mineralized
by osteoblasts. MMPs are zinc atom-dependent endopep-
tidases that play a primary role in the degradation of ECM
proteins [8]. Osteoblasts and osteocytes also produce
MMPs such as MMP-2 and MMP-13 [7,9]. The function
of MMP-2 is to degrade ECM proteins and promote
remodeling and regeneration of bone tissue [10].
Mitogen-activated protein kinases (MAPKs) are import-
ant signal transducing enzymes involved in cellular regula-
tion. Recent studies using a p38 mitogen-activated protein
kinase (p38 MAPK) inhibitor showed that cytokine stimu-
lation of MMP-2 synthesis is involved in p38 MAPK
signaling [11,12].
The purpose of this study was to clarify the effects of
EMD protein on the production and activation of MMP-
2 using an osteoblast-like cell line, that is, MG-63. We
found that EMD protein promoted the degradation of
gelatin on MG-63 cells and enhanced the activation oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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pathways depends on p38 MAPK. These results suggest
that selective regulation of MMP-2 production and sub-
sequent activation of MMP-2 by EMD protein in MG-63




Osteoblasts (MG-63 cell line; American Type Culture
Collection, Rockville, MA) were maintained in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with
10% heat-inactivated FBS (Equitech-Bio Inc., TX, USA), 2
mM glutamine and 100 units/ml penicillin/streptomycin
(Invitrogen, Carlsbad, CA) at 37°C in a humidified atmos-
phere of 5% CO2 in air.
DQ gelatin degradation assay
Coverslips were coated with 100 μg/ml quenched fluores-
cence substrate DQ-gelatin (Molecular Probes, Eugene,
OR). MG-63 cells were incubated with 100 μg/ml EMD
protein (Seikagaku-kogyo Corp., Osaka, Japan) in the
presence or absence of tissue inhibitor of metalloprotein-
ases-2 (TIMP-2; Dainippon Pharm Co., Toyama, Japan)
for 20 h, followed by incubating on DQ-gelatin-coated
plates for a period of 4 h. Cells were fixed with 2%
paraformaldehyde in PBS. Slides were mounted with
coverslips using glycerol/PBS, and examined with at
488 nm (excitation) and 533 nm (emission) using an
Olympus LSM-GB200 (Olympus, Tokyo, Japan) equipped
with an oil immersion lens. Differential interference
contrast (DIC) was used to visualize cells cultured on
the matrix.
Western blot analysis
MG-63 (1 × 106) cells were preincubated with 100 ng/ml
5 μM SB203580 (Chemicals Inc., Darmstadt, Germany)
for 30 min at 37°C, and MG-63 cells were then placed in
serum-free DMEM with 100 μg/ml EMD protein for 48 h.
Conditioned media were collected, centrifuged to remove
debris, and concentrated in Amicon Centriprep concen-
trators (Invitrogen) up to 10-fold. Cells were incubated in
serum-free Eagle medium with 100 μg/ml EMD protein
for 48 h. MG-63 cells prepared as described above were
lysed with SDS-sample buffer (80 mM Tris-HCl, 3% SDS,
15% glycerol and 0.01% bromophenol blue) and sonicated
briefly in order to shear DNA. Samples were separated on
10% SDS polyacrylamide gels (SDS-PAGE) under reducing
conditions. Proteins were electrophoretically transferred
to polyvinylidene difluoride (PVDF, Immobilon-P) mem-
branes (Sigma-Aldrich, Inc., St. Louis, MO). Membranes
were incubated for 1 h with anti-phospho-p38 antibody
(Cell Signaling Technology, Danvers, MA) or anti-p38
antibody (Cell Signaling Technology) in PBS containing0.05% Tween-20 and 10% Blockace (Dainippon Pharm
Co., Toyama, Japan). Peroxidase-conjugated secondary anti-
body (Amersham Biosciences, Piscataway, NJ) was used
at a 1:1,000 dilution and immunoreactive bands were
visualized using Super Signal west pico chemiluminescent
substrate (Pierce Biotechnology Inc., Rockford, IL). Signals
on each membrane were analyzed by VersaDoc 5000.
Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was isolated from MG-63 cells cells by RNeasy
kit (QIAGEN, Valencia, CA). MG-63 cells were then
placed in serum-free DMEM with 100 μg/ml EMD
protein for 12 h. After denaturation of total RNA at
70°C for 10 min, cDNA was synthesized with oligo-dT
primer by incubating with reverse transcriptase (Qiagen)
at 50°C for 30 min. The primers for MMP-2 were 5′-TG
GTTTTCCTCCATCCAGTGG-3′ (forward) and 5′-CA
GGTTGTCTGAAGTCACTGC-3′ (reverse). The primers
for GAPDH were 5′-ACC ACA GTC CAT GCC ATC
AC-3′ (forward) and 5′-TCC ACC ACC TTG CTG
CTG TA-3′ (reverse). Polymerase chain reactions were
performed with Pfu polymerase (Qiagen) initiated by 1
cycle at 95°C for 15 min followed by 30 cycles at 94°C
for 45 sec, 55°C for 45 sec, 72°C for 1 min and 1 cycle
at 72°C for 10 min for final extension. PCR products
were loaded to agarose gel, and stained with ethidium
bromide. The bands were analyzed using AlphaImager™
IS-3400 software. Briefly, IDV was measured as the sum
of all the pixel values after background correction in each
band. The values (AVG) of each band were calculated
as IND/AREA, where AREA is the size of the region
that was measured. The results are shown the values of
AVGMMP1/AVGGAPDH at each time point.
Results
EMD protein-stimulated MG-63 cells promoted
degradation of gelatin
In order to determine whether EMD protein is able to
facilitate osteoblast-mediated gelatin degradation, human
osteoblasts were incubated in the presence or absence
of 100 μg/ml EMD protein and plated on 100 μg/ml
DQ-gelatin-coated plates as described in the Methods
(Figure 1). Degradation of DQ-gelatin was visualized in
the optical section as a green fluorescent signal. Al-
though unstimulated MG-63 cells did not produce any
visible signals (panels A and C in Figure 1), EMD pro-
tein significantly enhanced degradation of gelatin (panels
D and F in Figure 1). Because gelatin is a substrate for
MMPs, it is possible that TIMP-2 could inhibit cell-
mediated degradation of gelatin. To test this hypothesis,
recombinant TIMP-2 was incubated with EMD and MG-
63 cells and then cultured on DQ-gelatin. TIMP-2 almost
completely eliminated degradation by EMD stimulated-
MG-63 cells (panels G and I in Figure 1), indicating that
Figure 1 EMD protein enhances MG-63 cells degradation of gelatin. MG-63 cells were incubated in the presence (D, E, F) or absence (A, B, C)
of 100 μg/ml EMD for 20 h, and were then incubated on glass coated with 100 μg/ml quenched fluorescent substrate DQ-gelatin for an additional
4 h. TIMP-2 (20 μM) was incubated with EMD protein and MG-63 cells as described above (G, H, I). Degradation of gelatin (green fluorescence) was
detected by a confocal microscope (Excitation: 488 nm; Emission: 530 nm). Images were obtained at ×40 magnification (A through I). Differential
interference contrast (DIC) images are shown. Quantification of GFP in Panels A-I was performed densitometrically using NIH image J software. Density
is depicted as mean GFP per cell.
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of MMP, which is a key step in the promotion of peri-
odontal connective tissue remodeling.EMD protein enhanced MMP-2 activity on MG-63 cells
We previously showed that MG-63 cells spontaneously
produced MMP-2, but not MMP-9 [10]. As shown in
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in MG-63 cells (Figure 1). Therefore, we also tested
whether EMD protein affected the production of MMP-
2 on 100 μg/ml gelatin-coated plates of MG-63 cells.
EMD protein (100 μg/ml) enhanced the production of
66-kDa, 68-kDa and 46-kDa MMP-2, which correspond
to the pro, intermediate and active forms of this enzyme,
respectively. Importantly, when EMD protein-activated
cells were cultured on gelatin-coated plates, generation
of the active form of MMP-2 was also observed (Figure 2A).
These results were confirmed by RT-PCR studies to
demonstrate that the transcription level of MMP-2 mRNA
was augmented in the presence of EMD compared to
unstimulated MG-63 cells (Figure 2B).
P38 MAPK pathway is involved in EMD protein-stimulated
MMP-2 activity on MG-63 cells
Previous studies have shown that p38 MAPK regulated
MMP-2 production induced by various cytokines [13].
Thus, it is possible that EMD protein also stimulatesFigure 2 Expression of MMP-2 from EMD protein-stimulated MG-63 c
100 μg/ml EMD protein for 24 h and conditioned media and total cell lysa
separated by 8% SDS-PAGE, blotted with anti-MMP-2 antibody and visualized
markers (kDa) are shown in the left column. Quantification of MMP-2 in the to
Peak heights of each density are depicted as percent of maximum valuel. (B)
EMD for 24 h and subjected to RT-PCR experiments by using specific primMAP kinases in osteoblasts cells to induce MMP-2 pro-
duction. To test this hypothesis, we first tested whether
EMD protein is able to activate p38 MAPK using Western
blotting analysis. When MG63 cells were cultured in the
presence of 100 μg/ml EMD protein on gelatin-coated
plates, p38 MAPK activation was observed in a time-
dependent manner, with the maximum phosphoryl-
ation at 5 min (top panel in Figure 3A). Total amount
of p38 MAPK protein was not affected (bottom panel
in Figure 3A). A synthetic specific inhibitor for p38
MAPK, SB203580, eliminated the activation of this kinase
in EMD protein-stimulated MG-63 cells (Figure 3B),
further indicating the activation of p38 MAPK in MG-
63 cells in the presence of EMD protein.
In order to further characterize the role of EMD
protein-induced p38 MAPK pathway activation, MG-63
cells were pretreated with SB203580, followed by EMD
protein stimulation. SB203580 significantly inhibited both
production and activation of MMP-2 by EMD protein on
MG-63 cells (Figure 4).ells. (A) MG-63 cells were incubated in serum-free Eagle containing
tes were prepared as described in Methods. Concentrated media were
with Super Signal west pico chemiluminescent substrate. Molecular
p panel was performed densitometrically using NIH image J software.
Total RNA was isolated from MG-63 cells cultured in the presence of
ers for MMP-2 (top) or GAPDH (bottom).
Figure 3 EMD-induced activation of p38 MAPK in MG-63 cells. (A) MG-63 cells were stimulated with 100 μg/ml EMD protein for the
indicated times at 37°C. Cells were harvested, and lysates were resolved in 10% SDS-PAGE and were transferred to a PVDF membrane. Membranes were
immunoblotted with anti-phospho-p38 MAPK antibody (top), and were then stripped and immunoblotted with anti- p38 MAPK antibody (bottom).
Molecular markers (kDa) are shown in the left column. (B) MG-63 cells were treated for 30 min with SB203580 (5 μM) before stimulation with 100 μg/ml
EMD protein for 5 min. Cells were harvested, and lysates were resolved in 10% SDS-PAGE and transferred to a PVDF membrane. The membrane was
immunoblotted with anti-phospho-p38 MAPK antibody (top), and was then stripped and immunoblotted with anti-p38 MAPK antibody (bottom).
Molecular markers (kDa) are shown in the left column. Quantification of p38 MAPK phosphorylation was performed densitometrically and corrected
against the amount of total p38 MAPK protein. Peak heights of each density are depicted as percent of maximum value.
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gelatin degradation by MG-63 cells
Finally, we confirmed these results in cell-mediated gelatin
degradation studies. MG-63 cells were incubated with
EMD protein in the presence or absence of SB203580,
and were then cultured on DQ-gelatin matrix. Consistent
with results in Figure 1, EMD protein enhanced the deg-
radation of gelatin (panels D, E, F, in Figure 5), as com-
pared with unstimulated MG-63 cells (panels A, B, C in
Figure 5). When SB203580 was co-incubated with EMD
protein, degradation of gelatin was stopped, as demon-
strated by a significant decrease in specific fluorescent sig-
nals (panels G, H, I in Figure 5). These findings suggest
that MMP-2 is a major gelatin-degrading enzyme pro-
duced by EMD protein-stimulated osteoblasts.
These results also suggest that EMD protein stimulates
matrix degradation involved in the catalytic activity of
MMP-2. Furthermore, our study highlights the pivotal
role for p38 MAP kinase pathways in inducing MMP-2
production from EMD protein-stimulated osteoblasts.Discussion
In this study, we showed that EMD protein stimulates
osteoblasts to degrade gelatin in vitro and that production
of MMP-2 is up-regulated in response to EMD protein
stimulation. Our results also suggest that adhesion to
gelatin enhances production of and activates pro-MMP-2,
which is spontaneously produced by osteoblasts. EMD
protein stimulates p38 MAPK signaling pathways, which
in turn, induce MMP-2 production by osteoblasts. Al-
though previous studies have shown that EMD protein
applied to periodontal defects is absorbed into the denuded
root dentin surface and induces periodontal tissue regener-
ation [14-16], the mechanisms of this action remain largely
unknown. In this regard, our results show the pivotal role
of MMP-2 produced from osteoblasts in response to EMD
protein in facilitating periodontal connective regeneration.
MMP-2 plays a crucial role in bone remodeling and
mineralization [17], and several studies have assessed the
functional roles of specific MMPs [18-20]. Our results
further support the importance of MMPs produced by
Figure 4 Effects of MEK on degradation of gelatin in EMD protein stimulated MG-63 cells. Concentrated conditioned media prepared from
unstimulated MG-63 cells (lane 1), EMD protein-stimulated MG-63 cells (5 μM) (lane 2), EMD protein-stimulated MG-63 cells in the presence of DEMSO
(lane 3), EMD protein-stimulated MG-63 cells cultured in the presence of SB203580 (5 μM) (lane 4) were separated on 8% SDS-PAGE. Membranes were
blotted with anti-MMP-2 antibody and visualized with Super Signal west pico chemiluminescent substrate. Molecular weight markers (kDa) are shown
in the left column. The same concentrated conditioned media were separated and transferred to membranes. Peak heights for each density are
depicted as percent of maximum value.
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The observations of residual degradation of ECM in the
presence of TIMP-2 may be explained by the involve-
ment of other proteases such as serine protease. Indeed,
recent studies have shown that osteoblasts express surface
serine protease [21]. However, the significant inhibition of
gelatin degradation by TIMP-2 suggests that EMD protein
enhances the production of MMPs on cell surfaces, which
facilitates osteoblast-mediated gelatinolysis. In the present
study, we demonstrated that MMP-2 is spontaneously pro-
duced from unstimulated osteoblasts, and that gelatinase is
activated in the presence of EMD protein. In contrast, pre-
vious studies have shown that gelatinase MMP-9 was not
produced by EMD protein-activated osteoblasts [10].
EMD protein contains both TGF-β- and BMP-like
growth factors, which contribute to the induction of
biomineralization during periodontal regeneration [22].
BMP-2 has been shown to promote bone regeneration
in vivo [23], enhance alkaline phosphatase activity [24,25],
and increase the production MMPs [26,27], thus suggest-
ing that the cytokines present in EMD are necessary to
promote bone regeneration. EMD protein also activates
alkaline phosphatase activity [28]. It is possible that the
TGF-β and BMP in EMD protein activate osteoblasts.Our data show that EMD protein enhances the produc-
tion MMP-2 by osteoblasts cells and suggest that bone
regeneration depends on MMP-2–activated EMD. These
papers support our data [29,30]. EMD protein have
decreased the levels of MMP-1 and MMP-8 in gingival
crevicular fluid after flap surgery in vivo [6].
EMD-induced VEGF production is regulated by p38
MAPK in human gingival fibroblasts [31].
We also provided evidence identifying p38 MAPK as the
predominant pathway for inducing MMP-2 production in
EMD-stimulated osteoblasts. Previous studies have shown
that this pathway is important to promote the growth
of PDL cells stimulated by EMD protein [32]. Thus, the
MAPK family, including the p38 MAPK, ERK and JNK
pathways activated by EMD protein, plays a key role in
regulating cellular functions required for periodontal
regeneration [33]. EMD-induced VEGF production is
regulated by p38 MAPK in human gingival fibroblasts
[31]. p38 MAPK might regulate not only MMPs produc-
tion, but also cytokine production in EMD stimulated
periodontal ligament. Our study also indicates that inhib-
ition of EMD protein-induced production of MMP-2
leads to significant reductions in the generation of active
MMP-2, further supporting the notion that MMP-2 acts
Figure 5 p38 MAPK pathways are important for EMD protein-stimulated MG-63 cell-mediated degradation of gelatin. Glass was coated
with 100 μg/ml of quenched fluorescent substrate DQ-gelatin. MG-63 cells were treated for 30 min with U0126 (5 μM). Cells were incubated in
the presence or absence of 100 μg/ml EMD protein for 20 h. Degradation of gelatin (green fluorescence) was detected using a confocal microscope
(Excitation: 488 nm; Emission: 530 nm). Images were obtained at ×40 magnification (A through I). Differential interference contrast (DIC) images are
shown. Density is depicted as mean GFP per cell.
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stimulated osteoblasts.
In summary, our results suggest a model in which MMP-
2 plays a role in periodontal connective tissue remodeling
by degrading matrix proteins and/or by activating a potent
gelatinase MMP-2 in osteoblasts.Conclusion
EMD protein induces MMP-2 production via the p-38
MAPK-activating signalling pathways in osteoblasts,
thereby stimulating degradation of the surrounding
collagen, resulting in changes in ECM structure and
promoting periodontal regeneration.
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